| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |